NOVOCURE LTD - NOTE 11/0

Historical Holders from Q4 2021 to Q3 2025

Type / Class
Debt / NOTE 11/0
Market price (% of par)
99.26%
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal
$561,598,000
Total reported market value
$558,197,754
Principal change
+$17,039,000
Market value change
+$18,416,916
Number of holders
20
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
25 filings reported holding 67011XAB9 - NOVOCURE LTD - NOTE 11/0.
NOVOCURE LTD - NOTE 11/0 has 20 institutional bondholders. These institutions hold $561,598,000 principal (par value) of the bond.

Institutional Holders of NOVOCURE LTD - NOTE 11/0 across Reporting Periods

Period Principal Value Change Price (% of par) Investors
2025 Q3 $561,598,000 $558,197,754 +$18,416,916 99.26% 20
2025 Q2 $555,717,000 $543,772,521 -$6,062,010 97.8% 23
2025 Q1 $550,788,000 $535,795,286 -$2,906,095,749 96.62% 17
2024 Q4 $552,975,000 $528,290,962 -$17,362,068 95.49% 17
2024 Q3 $571,249,000 $539,561,712 +$370,650 94.38% 18
2024 Q2 $570,899,000 $525,612,433 -$7,851,215 92.06% 18
2024 Q1 $580,224,000 $530,625,512 +$19,444,332 91.15% 23
2023 Q4 $562,281,003 $488,858,485 +$297,573 86.81% 22
2023 Q3 $559,014,992 $485,774,358 +$25,007,148 86.1% 24
2023 Q2 $528,082,199 $457,333,404 +$815,974 86.27% 32
2023 Q1 $526,832,450 $457,598,882 -$21,477,987 86.53% 31
2022 Q4 $550,683,196 $491,909,707 -$65,575,834 89.13% 32
2022 Q3 $408,289,989 $374,333,508 -$9,896,401 89.14% 31
2022 Q2 $396,659,196 $345,532,676 -$95,193,704 86.86% 32
2022 Q1 $546,867,200 $497,798,182 +$25,492,803 91.13% 45
2021 Q4 $515,731,000 $474,560,095 +$474,560,095 91.88% 37